Ross Cagan, Ph.D.
Professor, Department of Developmental and Regenerative Biology
Associate Dean, Graduate School of Biological Sciences
Mount Sinai School of Medicine
Dr. Cagan’s research laboratory focuses on a genetic and drug screening approach utilizing the fruit fly Drosophila that is targeted primarily at cancer and diabetes, including diabetic nephropathy. The focus is to use the advantages of the short life span of the fly to take a whole animal approach to disease since it is possible to evolve many generations in a relatively short time period. Dr. Cagan’s integrated approach brings genes and drugs identified in Drosophila research to other animal models models and ultimately to human studies. Dr. Cagan has been a faculty member of the Mount Sinai School of Medicine since 1994. He was educated at University of California, Los Angeles and received his Ph.D. from Princeton University.
Na J, Cagan R. The Drosophila nephrocyte: Back on stage. J Am Soc Nephrol. 2013; 24(2), 161-163.
Johnson RI, Bao S, Cagan RL. Interactions between Drosophila IgCAM adhesion receptors and cindr, the Cd2ap/Cin85 ortholog. Dev Dyn. 2012; 241(12), 1933-1943.
Cagan RL. The Drosophila nephrocyte. Curr Opin Nephrol Hypertens. 2011; 20(4), 409-415.
Rusconi JC, Fink JL, Cagan R. Klumpfuss regulates cell death in the Drosophila retina. Mech Dev. 2004; 121(6), 537-546.
Cagan R. The signals that drive kidney development: a view from the fly eye. Curr Opin Nephrol Hypertens. 2003; 12(1), 11-17.